Sen. Lamar Alexander of Tennessee has earned a reputation for seriousness, diligence and pragmatism. » Read More
By: Sophie Bearman
Paying for infertility care and controlling the number of embryos that are transferred would actually save money, some doctors say. » Read More
The White House says the true cost of the opioid drug epidemic in 2015 was $504 billion, or roughly half a trillion dollars. » Read More
U.S. President Donald Trump won't insist on including repeal of a health insurance mandate the tax-reform bill, a senior White House aide said on Sunday. » Read More
Startups do bad things sometimes.
Brexit is still well over year away but two European cities on Monday will already be celebrating Britain's departure from the European Union.
A drug addict's ability to stop is "no different" than a diabetic whose body can't regulate insulin levels, says Shatterproof's Gary Mendell.
The 2 percent increase in Social Security benefits will go toward paying the Part B premium.
A new report projects that up to 5 million people would become uninsured and the deficit would drop by $80 billion.
The Rev. Jesse Jackson disclosed publicly Friday that he has been seeking outpatient care for two years for Parkinson's disease.
Steve Pete and Reid Millius, with mirror-image genetic mutations, are helping companies develop better pain medicines.
Obamacare is seen favorably by 50 percent of Americans, and unfavorably by 46 percent, according to a Kaiser Family Foundation poll.
Automakers, including Toyota, Honda and Mercedes, are testing technology to monitor drivers for illnesses like heart disease and diabetes.
Tesla CEO Elon Musk unveiled the Tesla Semi truck on Thursday.
The condition of North Korea's latest escapee revealed worrying insights about health and hygiene in the rogue state.
Jim Cramer said the old-school tech company could be ready to make a comeback, despite the moves of Warren Buffett.
Jim Cramer sat down with Dexcom President and CEO Kevin Sayer, who said Abbott's glucose monitoring products have "nothing" on Dexcom's.
Jim Cramer zoomed in on the track record of Abbott CEO Miles White, who has transformed the company since he took over in 1999.
Goldman Sachs reiterates its buy rating for Intuitive Surgical shares, predicting the company will report earnings above expectations next year.
Senate Republicans want to kill Obamacare's individual mandate to free up almost $340 billion in federal spending.
Get the best of CNBC in your inbox